An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 1 - 12 of 12

  1. Assessment of the Adverse Health Effects of Aflatoxin Exposure from Unpackaged Peanut Oil in Guangdong, China

    • Toxins
    • Aflatoxins are liver carcinogens and are common contaminants in unpackaged peanut (UPP) oil. However, the health risks associated with consuming aflatoxins in UPP oil remain unclear. In this study, aflatoxin contamination in 143 UPP oil samples from Guangdong Province were assessed via liquid chromatography–tandem mass spectrometry (LC-MS). We also recruited 168 human subjects, who consumed this oil, to measure their liver functions and lipid metabolism status.

      • Natural toxins
      • Aflatoxins
      • Mycotoxins
      • Viruses
      • Hepatitis
  2. Evaluation of Toxicant-Associated Fatty Liver Disease and Liver Neoplastic Progress in Sprague-Dawley Rats Treated with Low Doses of Aflatoxin B1 Alone or in Combination with Extremely Low Frequency Electromagnetic Fields

    • Toxins
    • The term toxicant-associated fatty liver disease (TAFLD) has been proposed to describe fatty liver diseases connected to toxicants other than alcohol. Aflatoxins are mycotoxins commonly found as contaminants in foods and feeds, which are known liver toxicants and potential candidates as potential causes of TAFLD.

      • Natural toxins
      • Aflatoxins
      • Mycotoxins
      • Viruses
      • Hepatitis
  3. Foodborne Toxigenic Agents Investigated in Central Italy: An Overview of a Three-Year Experience (2018–2020)

    • Toxins
    • Foodborne diseases (FBDs) represent a worldwide public health issue, given their spreadability and the difficulty of tracing the sources of contamination. This report summarises the incidence of foodborne pathogens and toxins found in food, environmental and clinical samples collected in relation to diagnosed or suspected FBD cases and submitted between 2018 and 2020 to the Food Microbiology Unit of the Istituto Zooprofilattico Sperimentale del Lazio e della Toscana (IZSLT).

      • Viruses
      • COVID-19
  4. AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins

    • Toxins
    • Foodborne diseases affect an estimated 600 million people worldwide annually, with the majority of these illnesses caused by Norovirus, Vibrio, Listeria, Campylobacter, Salmonella, and Escherichia coli. To elicit infections in humans, bacterial pathogens express a combination of virulence factors and toxins.

      • Bacterial pathogens
      • Campylobacter
      • Escherichia coli O157:H7
      • Salmonella
      • Vibrio
      • Viruses
      • Norovirus
  5. Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure

    • Toxins
    • Hepatitis B virus (HBV) infection and aflatoxin B1 (AFB1) exposure have been recognized as independent risk factors for the occurrence and development of hepatocellular carcinoma (HCC), but their combined impacts and the potential metabolic mechanisms remain poorly characterized. Here, a comprehensive non-targeted metabolomic study was performed following AFB1 exposed to Hep3B cells at two different doses: 16 μM and 32 μM.

      • Hepatitis
      • Aflatoxins
      • Natural toxins
      • Viruses
  6. Mycotoxins in Ethiopia: A Review on Prevalence, Economic and Health Impacts

    • Toxins
    • Mycotoxigenic fungi and their toxins are a global concern, causing huge economic and health impacts in developing countries such as Ethiopia, where the mycotoxin control system is inadequate. This work aimed to review the occurrences of agriculturally essential fungi such as Aspergillus, Fusarium, and Penicillium and their major mycotoxins in Ethiopian food/feedstuffs.

      • Viruses
      • Hepatitis
      • Aflatoxins
      • Mycotoxins
      • Natural toxins
  7. Total Dietary Intake and Health Risks Associated with Exposure to Aflatoxin B1, Ochratoxin A and Fuminisins of Children in Lao Cai Province, Vietnam

    • Toxins
    • The health burden of foodborne mycotoxins is considerable, but particularly for children due to their lower detoxification capacity, rapid growth and high intake of food in proportion to their weight. Through a Total Dietary Study approach, the objective was to estimate the dietary exposure and health risk caused by mycotoxins for children under 5 years living in the Lao Cai province in northern Vietnam.

      • Natural toxins
      • Hepatitis
      • Viruses
      • Aflatoxins
      • Mycotoxins
  8. Toxins, Vol. 11, Pages 205: Exposure Assessment and Risk Characterization of Aflatoxin M1 Intake through Consumption of Milk and Yoghurt by Student Population in Serbia and Greece

    • Toxins
    • Toxins, Vol. 11, Pages 205: Exposure Assessment and Risk Characterization of Aflatoxin M1 Intake through Consumption of Milk and Yoghurt by Student Population in Serbia and Greece

      Toxins doi: 10.3390/toxins11040205

      Authors:
      Bozidar Udovicki
      Ilija Djekic
      Eleni P. Kalogianni
      Andreja Rajkovic

      • Natural toxins
      • Viruses
      • Hepatitis
      • Aflatoxins
  9. Toxins, Vol. 11, Pages 17: Lactobacillus bulgaricus or Lactobacillus rhamnosus Suppresses NF-κB Signaling Pathway and Protects against AFB1-Induced Hepatitis: A Novel Potential Preventive Strategy for Aflatoxicosis?

    • Toxins
    • Toxins, Vol. 11, Pages 17: Lactobacillus bulgaricus or Lactobacillus rhamnosus Suppresses NF-κB Signaling Pathway and Protects against AFB1-Induced Hepatitis: A Novel Potential Preventive Strategy for Aflatoxicosis?

      Toxins doi: 10.3390/toxins11010017

      Authors:
      Yuanyuan Chen
      Ruirui Li
      Qiaocheng Chang
      Zhihao Dong
      Huanmin Yang
      Chuang Xu

      • Hepatitis
      • Aflatoxins
      • Natural toxins
      • Viruses
  10. Toxins, Vol. 9, Pages 267: Recreational Exposure during Algal Bloom in Carrasco Beach, Uruguay: A Liver Failure Case Report

    • Toxins
    • Toxins, Vol. 9, Pages 267: Recreational Exposure during Algal Bloom in Carrasco Beach, Uruguay: A Liver Failure Case Report

      Toxins doi: 10.3390/toxins9090267

      Authors:
      Flavia Vidal
      Daniela Sedan
      Daniel D’Agostino
      María Cavalieri
      Eduardo Mullen
      María Parot Varela
      Cintia Flores
      Josep Caixach
      Dario Andrinolo

      • Hepatitis
      • Viruses
  11. Toxins, Vol. 9, Pages 23: Analysis of MicroRNA Expression Profiling Involved in MC-LR-Induced Cytotoxicity by High-Throughput Sequencing

    • Toxins
    • In recent years, microRNAs (miRNAs) in toxicology have attracted great attention. However, the underlying mechanism of miRNAs in the cytotoxicity of microcystin-LR (MC-LR) is lacking. The objective of this study is to analyze miRNA profiling in HepG2 cells after 24 h of MC-LR-exposure to affirm whether and how miRNAs were involved in the cytotoxicity of MC-LR.

      • Hepatitis
      • Viruses
  12. Toxins, Vol. 8, Pages 124: A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro

    • Toxins
    • Hepatitis B virus (HBV) infection is a major worldwide health problem which can cause acute and chronic hepatitis and can significantly increase the risk of liver cirrhosis and primary hepatocellular carcinoma (HCC). Nowadays, clinical therapies of HBV infection still mainly rely on nucleotide analogs and interferons, the usage of which is limited by drug-resistant mutation or side effects.

      • Hepatitis
      • Viruses